Rezolute, Inc.
- RZLT
- NASDAQ
- Biotechnology
- Rare Disease Biotech
- Hypoglycemia/Hyperinsulinism Therapy
$3.58
Today −8.21%Quote Oct 16, 2026, 08:00 PM UTC
−9.37%over the last month
Max drawdown −26.5%From 1-month high −26.5%3 months −19.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$346.3M
Quote Oct 16
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$9.17
+156.1% from here
Floor
$3.55
0.8% below price
Where the price sits
14 analysts
Analyst range, low to high
$6.00$14.00
- Price $3.58
- Resistance $4.16
- Consensus $9.17
The price is just above its floor. Analysts' average target sits about 156% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about RZLTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
58
Founded
2010